During the past decade, PersonGen BioTherapeutics (Suzhou) Co., Ltd. conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "PersonGen BioTherapeutics (Suzhou) Co., Ltd." #1 collaborator was "Hefei Binhu Hospital" with 7 trials as a collaborator, "The First People's Hospital of Hefei" with 7 trials as a collaborator and "Anhui Provincial Hospital" with 2 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "PersonGen BioTherapeutics (Suzhou) Co., Ltd." are "Acute Lymphocytic Leukemia" (3 trials), "B-cell Prolymphocytic Leukemia" (3 trials), "Chronic Lymphocytic Leukemia" (3 trials), "Diffuse Large Cell Lymphoma" (3 trials) and "Follicular Lymphoma" (3 trials). Many other conditions were trialed in "PersonGen BioTherapeutics (Suzhou) Co., Ltd." in a lesser frequency.

Most popular intervention types in "PersonGen BioTherapeutics (Suzhou) Co., Ltd." are "Biological" (8 trials). Other intervention types were less common.

The name of intervention was led by "PCAR-019 (anti-CD19 CAR-T cells)" (2 trials), "anti-CD19 CAR-NK cells" (1 trials), "anti-CD33 CAR-NK cells" (1 trials), "anti-CD7 CAR-pNK cells" (1 trials) and "anti-MUC1 CAR T Cells" (1 trials). Other intervention names were less common.

The vast majority of trials in "PersonGen BioTherapeutics (Suzhou) Co., Ltd." are 8 trials for "All" genders.

Currently, there are NaN active trials in "PersonGen BioTherapeutics (Suzhou) Co., Ltd.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in PersonGen BioTherapeutics (Suzhou) Co., Ltd., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in PersonGen BioTherapeutics (Suzhou) Co., Ltd., 8 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".